PIRAMAL PHARMA LIMITED (PPLPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 846.43 994.24 1,024.14 1,525.30 1,063.20 1,284.39 1,248.32 1,689.80 969.88 1,127.26 1,195.81 1,489.06
YOY Revenue Growth % - 19.95% 25.93% 44.64% 25.61% 29.18% 21.89% 10.78% -8.78% -12.23% -4.21% -11.88%
Other Income 26.68 89.08 33.11 53.19 36.76 106.38 24.70 39.51 180.92 201.97 96.15 183.69
Total Income 873.11 1,083.32 1,057.25 1,578.49 1,099.96 1,390.77 1,273.02 1,729.31 1,150.80 1,329.23 1,291.96 1,672.75
Total Expenses + 743.14 763.58 848.12 854.06 867.48 870.10 971.69 1,364.95 1,008.22 1,081.82 1,110.09 1,275.33
Cost of Materials Consumed 326.33 356.76 444.94 417.52 405.76 380.22 474.23 336.72 409.76 350.95 347.06 234.93
Employee Benefit Expense 159.05 151.44 150.56 152.88 186.96 176.72 173.55 198.96 201.95 188.52 187.80 166.55
Other Expenses 257.76 255.38 252.62 283.66 274.76 313.16 323.91 351.29 297.44 355.04 307.86 364.95
Operating Profit 103.30 230.66 176.02 671.24 195.72 414.29 276.63 324.85 -38.34 45.44 85.72 213.73
OPM % 12.2% 23.2% 17.2% 44% 18.4% 32.3% 22.2% 19.2% -4% 4% 7.2% 14.4%
Profit Before Tax + -40.90 96.19 89.66 362.67 111.66 275.71 159.41 364.36 142.58 247.41 154.93 331.85
Tax Expense -7.54 19.03 15.32 89.59 26.39 65.65 40.61 87.09 29.44 51.08 26.02 70.22
Tax % - 19.8% 17.1% 24.7% 23.6% 23.8% 25.5% 23.9% 20.6% 20.6% 16.8% 21.2%
Profit After Tax -33.36 77.16 74.34 273.08 85.27 210.06 118.80 277.27 113.14 196.33 128.91 261.63
EPS (Basic) -0.28 0.61 0.56 2.06 0.64 1.59 0.90 2.09 0.85 1.48 0.97 1.97

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 5,285.71 4,390.11 3,443.22
YOY Revenue Growth % 20.4% 27.5% -
Other Income 207.35 202.06 341.07
Total Income 5,493.06 4,592.17 3,784.29
Total Expenses + 4,581.92 3,208.90 2,743.69
Cost of Materials Consumed 1,596.93 1,545.55 1,166.48
Employee Benefit Expense 736.19 613.93 548.50
Other Expenses 1,263.12 1,049.42 1,028.71
Operating Profit 703.79 1,181.21 699.53
OPM % 13.3% 26.9% 20.3%
Profit Before Exceptional 911.14 507.62 130.65
Exceptional Items 0.00 0.00 -6.96
Profit Before Tax + 911.14 507.62 123.69
Tax Expense 219.74 116.40 54.19
Tax % 24.1% 22.9% 43.8%
Profit After Tax 691.40 391.22 69.50
EPS (Basic) 5.22 3.05 0.58

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 6,855.95 6,259.33 5,693.72
Property, Plant & Equipment 2,010.75 1,727.28 1,673.56
Capital Work in Progress 77.68 232.40 136.50
Non-Current Investments 3,105.31 1,646.88 1,646.87
Goodwill 160.55 160.55 160.55
Other Intangible Assets 604.91 601.03 645.26
Current Assets + 3,535.88 3,291.55 2,348.68
Inventories 1,205.35 1,153.04 818.61
Trade Receivables 1,666.69 1,331.38 909.56
Cash and Cash Equivalents 163.87 228.80 54.28
Current Investments 0.00 61.28 100.12
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00
Equity Share Capital 1,324.35 1,322.95 1,193.32
Other Equity 6,128.19 5,389.12 4,068.47
Non-Current Liabilities 632.80 610.99 829.32
Current Liabilities 2,306.49 2,227.82 1,951.29
Total Liabilities 2,939.29 2,838.81 2,780.61

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities 548.77 358.29 71.52
Cash from Investing Activities -549.98 -635.52 -435.05
Cash from Financing Activities -61.74 451.38 290.12
Net Increase/Decrease in Cash -64.93 174.52 -73.41